CHMG on Nasdaq
CHEMUNG FINANCIAL CORP
Price unavailable
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
WMG Fee Income brought in 35% of the revenue CHEMUNG FINANCIAL CORP broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| WMG Fee Income | $11.6M | $11.9M |
| Wealth Management Group Services | $11.6M | $11.9M |
| Interchange Revenue | $4.4M | $4.3M |
| Overdraft Fees | $3.0M | $2.9M |
| Service Charge on Deposits, Other | $1.0M | $1.6M |
| Investment Brokerage | $1.1M | $1.2M |
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Loans, including fees | $120.4M | $112.1M |
| Taxable securities | $8.9M | $13.0M |
| Tax exempt securities | $620.0K | $1.0M |
| Interest-earning deposits | $3.0M | $1.4M |
| Total interest and dividend income | $132.8M | $127.6M |
| Deposits | $41.8M | $50.1M |
| Borrowed funds | $3.9M | $3.5M |
| Total interest expense | $45.7M | $53.5M |
| Net interest income | $87.2M | $74.1M |
| Provision (credit) for credit losses | $4.4M | -$46.0K |
| Net interest income after provision for credit losses | $82.7M | $74.1M |
| Net (losses) on securities transactions | -$17.5M | $0 |
| Change in fair value of equity investments | $211.0K | $179.0K |
| Net gain on sales of loans held for sale | $261.0K | $214.0K |
| Net gains (losses) on sales of other real estate owned | $2.0K | -$18.0K |
| Income from bank owned life insurance | $32.0K | $38.0K |
| Other | $4.3M | $2.8M |
| Total non-interest income | $7.9M | $23.2M |
| Salaries and wages | $30.6M | $28.5M |
| Pension and other employee benefits | $8.9M | $8.1M |
| Other components of net periodic pension cost (benefit) | -$452.0K | -$909.0K |
| Net occupancy expense | $5.8M | $5.8M |
| Furniture and equipment expense | $1.7M | $1.7M |
| Data processing expense | $10.0M | $10.1M |
| Professional services | $2.7M | $2.4M |
| Marketing and advertising expense | $1.2M | $1.2M |
| Other real estate owned expense | $23.0K | $157.0K |
| FDIC insurance | $1.5M | $2.1M |
| Loan expense | $1.2M | $1.2M |
| Other | $7.5M | $7.0M |
| Total non-interest expense | $70.7M | $67.2M |
| Income before income tax expense | $19.9M | $30.1M |
| Income tax expense | $4.8M | $6.4M |
| Net income | $15.1M | $23.7M |
| Weighted average shares outstanding, basic (in shares) | 4.8M shares | 4.8M shares |
| Weighted average shares outstanding, diluted (in shares) | 4.8M shares | 4.8M shares |
| Basic earnings per share (in dollars per share) | $3.14 | $4.96 |
| Diluted earnings per share (in dollars per share) | $3.14 | $4.96 |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2024-05-31 |
|---|---|---|---|
| Cash and due from financial institutions | $22.8M | $26.2M | |
| Interest-earning deposits in other financial institutions | $27.3M | $20.8M | |
| Total cash and cash equivalents | $50.1M | $47.0M | |
| Equity investments, at fair value | $3.8M | $3.2M | |
| Securities available for sale, at estimated fair value (amortized cost of $327,888, net of allowance for credit losses of $0 as of December 31, 2025; and amortized cost of $617,271, net of allowance for credit losses of $0 as of December 31, 2024) | $280.6M | $531.4M | |
| Securities held to maturity, (estimated fair value of $640 as of December 31, 2025 and $808 as of December 31, 2024 net of allowance for credit losses of $0 as of December 31, 2025 and December 31, 2024) | $640.0K | $808.0K | |
| FHLBNY and FRBNY Stock, at cost | $9.5M | $9.1M | |
| Loans, net of deferred loan fees | $2.3B | $2.1B | |
| Allowance for credit losses | -$24.2M | -$21.4M | |
| Loans, net | $2.2B | $2.1B | |
| Loans held for sale | $2.1M | $0 | |
| Premises and equipment, net | $15.4M | $16.4M | |
| Operating lease right-of-use assets | $4.8M | $5.4M | |
| Goodwill | $21.8M | $21.8M | |
| Bank owned life insurance | $3.0M | $3.0M | |
| Interest rate swap assets | $17.3M | $23.8M | |
| Accrued interest receivable and other assets | $56.0M | $64.1M | |
| Total assets | $2.7B | $2.8B | |
| Non interest-bearing | $624.5M | $625.8M | |
| Interest-bearing | $1.6B | $1.8B | |
| Total deposits | $2.3B | $2.4B | |
| FHLBNY overnight advances | $87.1M | $109.1M | |
| Subordinated debt, net of issuance costs of $972 and $0, respectively | $44.0M | $0 | |
| Long-term finance lease obligation | $3.4M | $3.8M | $900.0K |
| Operating lease liabilities | $4.9M | $5.6M | |
| Interest rate swap liabilities | $17.4M | $23.9M | |
| Accrued interest payable and other liabilities | $27.9M | $21.6M | |
| Total liabilities | $2.5B | $2.6B | |
| Common stock, $0.01 par value per share, 10,000,000 shares authorized; 5,310,076 issued as of December 31, 2025 and December 31, 2024 | $53.0K | $53.0K | |
| Additional-paid-in capital | $49.5M | $48.8M | |
| Retained earnings | $256.5M | $247.7M | |
| Treasury stock, at cost (519,079 shares as of December 31, 2025; 555,881 shares as of December 31, 2024) | -$15.3M | -$16.2M | |
| Accumulated other comprehensive (loss) | -$36.1M | -$65.1M | |
| Total shareholders' equity | $254.7M | $215.3M | |
| Total liabilities and shareholders' equity | $2.7B | $2.8B | |
| Debt securities available for sale, amortized cost | $327.9M | $617.3M | |
| Debt securities available for sale, allowance for credit loss | $0 | $0 | |
| Debt securities, held-to-maturity, fair value | $640.0K | $808.0K | |
| Debt securities, held-to-maturity, allowance for credit loss | $0 | $0 | |
| Subordinated debt, net of issuance costs | $972.0K | $0 | |
| Common stock par value (in dollars per share) | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 10.0M shares | 10.0M shares | |
| Common stock, shares issued (in shares) | 5.3M shares | 5.3M shares | |
| Treasury stock, at cost (in shares) | 519.1K shares | 555.9K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income | $15.1M | $23.7M |
| Amortization of right-of-use assets | $771.0K | $202.0K |
| Deferred income tax (benefit) expense | -$2.7M | $1.1M |
| Provision (credit) for credit losses | $4.4M | -$46.0K |
| Gains on disposal of fixed assets | -$640.0K | -$39.0K |
| Depreciation and amortization of fixed assets | $1.9M | $1.8M |
| Amortization of premiums on securities, net | $1.4M | $2.3M |
| Gains on sales of loans held for sale, net | -$261.0K | -$214.0K |
| Proceeds from sales of loans held for sale | $14.1M | $11.9M |
| Loans originated and held for sale | -$13.9M | -$11.7M |
| (Gains) losses on sale of other real estate owned, net | -$2.0K | $18.0K |
| Write-downs on other real estate owned | $0 | $45.0K |
| Change in fair value of equity investments, net | -$211.0K | -$179.0K |
| Losses on securities transactions, net | $17.5M | $0 |
| Purchases of equity investments, net | -$319.0K | -$10.0K |
| Amortization of deferred costs on subordinated debt | $56.0K | $0 |
| Losses (gains) on interest rate swaps, net | $110.0K | -$17.0K |
| Income from bank owned life insurance | -$32.0K | -$38.0K |
| Decrease (increase) in accrued interest receivable | $361.0K | -$486.0K |
| Decrease (increase) in other assets | $4.5M | -$2.2M |
| Increase (decrease) in accrued interest payable | -$1.6M | $487.0K |
| Increase (decrease) in other liabilities | $4.1M | $2.1M |
| Payments on operating leases | -$772.0K | -$198.0K |
| Expense related to restricted stock units for directors' deferred compensation plan | $23.0K | $21.0K |
| Expense related to employee restricted stock awards | $1.4M | $1.2M |
| Net cash provided by operating activities | $45.5M | $29.8M |
| Proceeds from sales, maturities, calls, and principal paydowns on securities available for sale | $274.4M | $54.5M |
| Proceeds from sales, maturities and principal collected on securities held to maturity | $328.0K | $177.0K |
| Purchases of securities available for sale | -$4.0M | -$5.0M |
| Purchases of securities held to maturity | -$160.0K | -$200.0K |
| Purchase of FHLBNY and FRBNY stock | -$16.4M | -$31.7M |
| Redemption of FHLBNY and FRBNY stock | $16.0M | $28.0M |
| Proceeds from sales of fixed assets | $1.4M | $44.0K |
| Purchases of premises and equipment | -$1.7M | -$3.6M |
| Proceeds from sale of other real estate owned | $413.0K | $403.0K |
| Net (increase) in loans | -$202.1M | -$100.5M |
| Net cash (used in) provided by investing activities | $68.3M | -$57.7M |
| Net increase (decrease) in demand, interest-bearing demand, savings, and insured money market deposits | $34.1M | -$44.2M |
| Net increase (decrease) in time deposits | -$160.3M | $11.6M |
| Net increase (decrease) in FHLBNY overnight advances | -$22.0M | $77.2M |
| Increases in (payments on) finance leases | -$335.0K | $729.0K |
| Proceeds from subordinated debt issuance | $45.0M | $0 |
| Payment of subordinated debt issuance costs | -$1.0M | $0 |
| Purchase of treasury stock | -$396.0K | -$344.0K |
| Sale of treasury stock | $536.0K | $430.0K |
| Cash dividends paid | -$6.3M | -$7.4M |
| Net cash (used in) provided by financing activities | -$110.8M | $38.1M |
| Net increase (decrease) in cash and cash equivalents | $3.1M | $10.2M |
| Interest | $47.3M | $53.0M |
| Income Taxes | $6.3M | $6.1M |
| Transfer of portfolio loans to loans held for sale | $2.1M | $0 |
| Transfer of loans to other real estate owned | $0 | $552.0K |
| Transfer of fixed assets held for sale | $0 | $671.0K |
| Right-of-use assets obtained through finance lease liabilities | $0 | $935.0K |
| Right-of-use assets obtained through operating leases liabilities | $80.0K | $570.0K |
Recent filings
- Oct 1, 20268-K
- Sep 17, 20264
- Sep 15, 2026144
- Aug 19, 20268-K
- Aug 12, 20264
- Aug 11, 20263
- Aug 6, 202610-Q
- Jul 27, 20268-K
- Jul 22, 20268-K
- Jul 15, 2026SCHEDULE 13G/A
- Jul 6, 20264
- Jun 25, 20264
- Jun 10, 202611-K
- Jun 2, 20268-K
- May 21, 20268-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10